DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20212249

Pancreatic cancer in obstructive jaundice in unexpected age

Karmen Bahnam Katay, Reem Hamed Khamis, Thafar Salim Al Safar

Abstract


Cancer of the pancreas is a highly lethal malignancy. It is considered as the fourth leading cause of cancer-related death in the United States and second only to colorectal cancer as a cause of digestive cancer-related death.It is hoped that detection of asymptomatic and early stage of disease is potentially curable pancreatic cancer and it will improve outcomes. Our case report is 45 years old female who presented at our primary health care centre with obstructive jaundice for only 2 weeks and no weight loss, vague abdominal pain. She had intermittent epigastric pain for past few months and diagnosed as gastroesophageal reflex. Also, she had chronic anemia and need blood transfusion in the past 3 years. No family history of pancreatic cancer and no other risk factor. Most articles reveal difficulty in diagnosing pancreatic cancer in early stage and young age group due to its resemblance to benign lesion. That’s why we prefer to do case report for documentation. Diagnosis of the tumor is important especially in early stages for improving prognosis.


Keywords


Pancreatic cancer, Obstructive jaundice, Early detection

Full Text:

PDF

References


Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7.

GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4:934

Blackford AL, Canto MI, Klein AP. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis. J Natl Cancer Inst. 2020;112:1162.

Allen PJ, Kuk D, Castillo CF. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients with Pancreatic Adenocarcinoma. Ann Surg. 2017;265:185.

Zhang J, Dhakal I, Ning B, Kesteloot H. Patterns and trends of pancreatic cancer mortality rates in Arkansas, 1969-2002: a comparison with the US population. Eur J Cancer Prev. 2008;17:18.

Howlader N, Noone AM, Krapcho M, Miller D. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda Available at: https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. https://seer.cancer.gov/csr/1975_2017/. Accessed on April 01, 2021.

Rebours V, Lévy P, Ruszniewski P. An overview of hereditary pancreatitis. Dig Liver Dis. 2012;44:8.

Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am. 2000;84:565.

Carreras-Torres R, Johansson M, Gaborieau V. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. J Natl Cancer Inst. 2017;109.

Lucenteforte E, La Vecchia C, Silverman D. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 2012; 23:374.

Huxley R, Ansary-Moghaddam A, Berrington de González A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92:2076.

Klein AP, Hruban RH, Brune KA. Familial pancreatic cancer. Cancer J. 2001;7:266.

Olson SH, Kurtz RC. Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol. 2013;107:1.

Kalser MH, Barkin J, MacIntyre JM. Pancreatic cancer. Assessment of prognosis by clinical presentation. Cancer. 1985;56:397.

Manabe T, Miyashita T, Ohshio G. Small carcinoma of the pancreas. Clinical and pathologic evaluation of 17 patients. Cancer. 1988;62:135.